Plant-Based Vaccines Market
完整報告名稱與涵蓋範圍
Plant-Based Vaccines Market Size, Share & Trends Analysis Distribution by Vaccine Type (Viral Vaccines, Bacterial Vaccines, Parasite & Other Vaccines), Application (Influenza, COVID-19, Veterinary Diseases, Other Infectious Diseases, Therapeutic Vaccines), Source (Tobacco (Nicotiana benthamiana), Cereal Crops (Maize, Rice), Other Plants (Potatoes, Lettuce, Spirulina), Plant Cell Cultures (Carrot, Tobacco)), End-User (Veterinary Sector, Human Healthcare, Research Institutions) and Segment Forecasts, 2025-2034
報告摘要
The worldwide Plant-Based Vaccines Market stood at USD 409.5 Mn in 2024, and is projected to reach USD 2,161.2 Mn by 2034, recording a CAGR of 18.2% from 2025 through 2034.
Plant-Based Vaccines covers key industry insights & findings from the report:
Growing interest from both the public and private sectors has led to increased investment in plant-based vaccine research and development. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is propelled by expanding appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Plant-Based Vaccines Market Snapshot
Chapter 4. Global Plant-Based Vaccines Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Plant-Based Vaccines Market Industry Trends
4.10. Global Plant-Based Vaccines Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Plant-Based Vaccines Market Segmentation 1: By Vaccine Type, Estimates & Trend Analysis
5.1. Market Share by Vaccine Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Vaccine Type:
5.2.1. Viral Vaccines
5.2.2. Bacterial Vaccines
5.2.3. Parasite & Other Vaccines
Chapter 6. Plant-Based Vaccines Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the
following Application:
6.2.1. Influenza
6.2.2. COVID-19
6.2.3. Veterinary Diseases
6.2.4. Other Infectious Diseases
6.2.5. Therapeutic Vaccines
Chapter 7. Plant-Based Vaccines Market Segmentation 3: By Source, Estimates & Trend Analysis
7.1. Market Share by Source, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source:
7.2.1. Tobacco (Nicotiana benthamiana)
7.2.2. Cereal Crops (Maize, Rice)
7.2.3. Other Plants (Potatoes, Lettuce, Spirulina)
7.2.4. Plant Cell Cultures (Carrot, Tobacco)
Chapter 8. Plant-Based Vaccines Market Segmentation 3: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
8.2.1. Veterinary Sector
8.2.2. Human Healthcare
8.2.3. Research Institutions
Chapter 9. Plant-Based Vaccines Market Segmentation 4: Regional Estimates & Trend Analysis
9.1. Global Plant-Based Vaccines Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2021-2034
9.2.3. North America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. North America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.2.5. North America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.3. Europe
9.3.1. Europe Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2021-2034
9.3.3. Europe Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Europe Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.3.5. Europe Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2021-2034
9.4.3. Asia Pacific Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Asia Pacific Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.4.5. Asia Pacific Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.5. Latin America
9.5.1. Latin America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2021-2034
9.5.3. Latin America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Latin America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.5.5. Latin America Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2021-2034
9.6.3. Middle East & Africa Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.4. Middle East & Africa Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
9.6.5. Middle East & Africa Plant-Based Vaccines Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Dow AgroSciences
10.2.1.1. Business Overview
10.2.1.2. Key Vaccine Type/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Aramis Biotechnologies
10.2.3. Protalix Biotherapeutics
10.2.4. iBio Inc. (USA)
10.2.5. Kentucky BioProcessing (USA)
10.2.6. Baiya Phytopharm (Thailand)
10.2.7. Icon Genetics (Germany)
10.2.8. LenioBio (Germany)
10.2.9. Lumen Bioscience (USA)
10.2.10. Leaf Expression Systems (UK)
10.2.11. ZYUS Life Sciences (Canada)
10.2.12. PlantForm Corporation (Canada)
10.2.13. Fraunhofer CMB (USA)
10.2.14. Mazen Animal Health (USA)
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們